Medical Image Analysis Software Market

Executive Summary

Medical Image Analysis Software Market was valued at US $3,618.90 million in 2021 and is projected to grow at 7.72% CAGR over the forecast period to reach US $5,653.49 million by 2027. Medical Image Analysis Software Market represented US $500.03 million opportunity over 2019-2021 and estimated to create US $2,034.59 million opportunity in 2027 over 2021.

Medical Image Analysis Software from Consainsights analyses the Medical Image Analysis Software Market in the Technology & Media industry over the forecast period to 2027.

Medical Image Analysis Software research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Image Analysis Software segmentation includes Type, Image Type, Modality, Application, End User, Region and Geography.

Based on the Type, the Medical Image Analysis Software analysis covers Integrated Software, Standalone Software.

In Type segment, Integrated Software segment has highest cagr growth of 6.83%.

Based on the Image Type, the Medical Image Analysis Software analysis covers Imaging.

In Image Type segment, Imaging segment has highest cagr growth of 6.83%.

Based on the Modality, the Medical Image Analysis Software analysis covers Tomography, Ultrasound Imaging, Radiographic Imaging, Combined Modalities.

In Modality segment, Tomography segment has highest cagr growth of 6.83%.

Based on the Application, the Medical Image Analysis Software analysis covers Cardiology Applications, Orthopedics, Oncology Applications, Neurology, Obstetrics and Gynecology, Mammography Applications, Dental Applications, Respiratory Applications, Urology and Nephrology.

In Application segment, Cardiology Applications segment has highest cagr growth of 6.83%.

Based on the End User, the Medical Image Analysis Software analysis covers Hospitals, Diagnostic Centers, Research Centers.

In End User segment, Hospitals segment has highest cagr growth of 6.83%.

Based on the Region, the Medical Image Analysis Software analysis covers North America, Europe, Asia, Rest of the World.

In Region segment, North America segment has highest cagr growth of 6.83%.

Based on the region, the Medical Image Analysis Software analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Integrated Software segment has the highest revenue of US $2,061.05 million and is expected to grow at CAGR of 6.83% by 2027 Integrated Software segment has highest cagr growth of 6.83%.

Integrated Software

Integrated Software segment was valued at US $1,776.27 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $3,219.80 million by 2027. Integrated Software segment represented US $284.78 million opportunity over 2019-2021 and estimated to create US $1,158.75 million opportunity in 2027 over 2021.

Standalone Software

Standalone Software segment was valued at US $737.28 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,336.44 million by 2027. Standalone Software segment represented US $118.20 million opportunity over 2019-2021 and estimated to create US $480.96 million opportunity in 2027 over 2021.

Image Type

Introduction

In 2021, Imaging segment has the highest revenue of US $1,934.75 million and is expected to grow at CAGR of 6.83% by 2027 Imaging segment has highest cagr growth of 6.83%.

Imaging

Imaging segment was valued at US $1,667.42 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $3,022.48 million by 2027. Imaging segment represented US $267.33 million opportunity over 2019-2021 and estimated to create US $1,087.74 million opportunity in 2027 over 2021.

Modality

Introduction

In 2021, Tomography segment has the highest revenue of US $1,961.04 million and is expected to grow at CAGR of 6.83% by 2027 Tomography segment has highest cagr growth of 6.83%.

Tomography

Tomography segment was valued at US $1,690.08 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $3,063.57 million by 2027. Tomography segment represented US $270.96 million opportunity over 2019-2021 and estimated to create US $1,102.52 million opportunity in 2027 over 2021.

Ultrasound Imaging

Ultrasound Imaging segment was valued at US $630.72 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,143.29 million by 2027. Ultrasound Imaging segment represented US $101.12 million opportunity over 2019-2021 and estimated to create US $411.45 million opportunity in 2027 over 2021.

Radiographic Imaging

Radiographic Imaging segment was valued at US $657.08 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,191.06 million by 2027. Radiographic Imaging segment represented US $105.35 million opportunity over 2019-2021 and estimated to create US $428.64 million opportunity in 2027 over 2021.

Combined Modalities

Combined Modalities segment was valued at US $140.99 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $255.56 million by 2027. Combined Modalities segment represented US $22.60 million opportunity over 2019-2021 and estimated to create US $91.97 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiology Applications segment has the highest revenue of US $1,400.71 million and is expected to grow at CAGR of 6.83% by 2027 Cardiology Applications segment has highest cagr growth of 6.83%.

Cardiology Applications

Cardiology Applications segment was valued at US $1,207.17 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $2,188.21 million by 2027. Cardiology Applications segment represented US $193.54 million opportunity over 2019-2021 and estimated to create US $787.50 million opportunity in 2027 over 2021.

Orthopedics

Orthopedics segment was valued at US $754.48 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,367.63 million by 2027. Orthopedics segment represented US $120.96 million opportunity over 2019-2021 and estimated to create US $492.19 million opportunity in 2027 over 2021.

Oncology Applications

Oncology Applications segment was valued at US $466.32 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $845.28 million by 2027. Oncology Applications segment represented US $74.76 million opportunity over 2019-2021 and estimated to create US $304.20 million opportunity in 2027 over 2021.

Neurology

Neurology segment was valued at US $264.58 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $479.59 million by 2027. Neurology segment represented US $42.42 million opportunity over 2019-2021 and estimated to create US $172.60 million opportunity in 2027 over 2021.

Obstetrics and Gynecology

Obstetrics and Gynecology segment was valued at US $165.57 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $300.13 million by 2027. Obstetrics and Gynecology segment represented US $26.55 million opportunity over 2019-2021 and estimated to create US $108.01 million opportunity in 2027 over 2021.

Mammography Applications

Mammography Applications segment was valued at US $113.50 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $205.74 million by 2027. Mammography Applications segment represented US $18.20 million opportunity over 2019-2021 and estimated to create US $74.04 million opportunity in 2027 over 2021.

Dental Applications

Dental Applications segment was valued at US $76.35 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $138.41 million by 2027. Dental Applications segment represented US $12.24 million opportunity over 2019-2021 and estimated to create US $49.81 million opportunity in 2027 over 2021.

Respiratory Applications

Respiratory Applications segment was valued at US $37.85 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $68.61 million by 2027. Respiratory Applications segment represented US $6.07 million opportunity over 2019-2021 and estimated to create US $24.69 million opportunity in 2027 over 2021.

Urology and Nephrology

Urology and Nephrology segment was valued at US $33.04 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $59.88 million by 2027. Urology and Nephrology segment represented US $5.30 million opportunity over 2019-2021 and estimated to create US $21.55 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $1,667.77 million and is expected to grow at CAGR of 6.83% by 2027 Hospitals segment has highest cagr growth of 6.83%.

Hospitals

Hospitals segment was valued at US $1,437.33 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $2,605.41 million by 2027. Hospitals segment represented US $230.44 million opportunity over 2019-2021 and estimated to create US $937.64 million opportunity in 2027 over 2021.

Diagnostic Centers

Diagnostic Centers segment was valued at US $1,300.06 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $2,356.59 million by 2027. Diagnostic Centers segment represented US $208.43 million opportunity over 2019-2021 and estimated to create US $848.09 million opportunity in 2027 over 2021.

Research Centers

Research Centers segment was valued at US $381.47 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $691.48 million by 2027. Research Centers segment represented US $61.16 million opportunity over 2019-2021 and estimated to create US $248.85 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $1,375.73 million and is expected to grow at CAGR of 6.83% by 2027 North America segment has highest cagr growth of 6.83%.

North America

North America segment was valued at US $1,185.64 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $2,149.18 million by 2027. North America segment represented US $190.09 million opportunity over 2019-2021 and estimated to create US $773.45 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $925.01 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,676.74 million by 2027. Europe segment represented US $148.30 million opportunity over 2019-2021 and estimated to create US $603.43 million opportunity in 2027 over 2021.

Asia

Asia segment was valued at US $723.73 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $1,311.90 million by 2027. Asia segment represented US $116.03 million opportunity over 2019-2021 and estimated to create US $472.13 million opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $284.48 million in 2019 and is projected to grow at 6.83% CAGR over the forecast period to reach US $515.66 million by 2027. Rest of the World segment represented US $45.61 million opportunity over 2019-2021 and estimated to create US $185.58 million opportunity in 2027 over 2021.